BioIVT Opens New Blood Donor Center in Glasgow, Scotland

Located in the West of Scotland Science Park, this new facility will produce fresh leukopaks for cell and gene therapy research in the UK and Europe.

Dr. Brett King Joins BiologicsMD as Senior Scientific Advisor and Member of the Scientific Advisory Board

BiologicsMD, a preclinical therapeutic development company focused on highly-targeted treatments for hair loss and bone disorders, announced today the appointment of Brett King, MD, PhD, Associate Professor of Dermatology at Yale Medical School, as a Senior Scientific Advisor to the company’s management team and Board of Directors.

Quotient Sciences Completes Major Expansion of Drug Substance Manufacturing Facility

Quotient Sciences, the drug development and manufacturing accelerator, has completed the expansion of its drug substance manufacturing facility in Alnwick, UK.

Huateng Pharma Develops A novel chemiluminescent Substrate APS-5

Industry, academia, and policy makers set to discuss the future of healthcare at Pharma Integrates 2022

Taking place on 17th November in London, Pharma Integrates is the must-attend event for leaders, strategists and innovators across pharma & healthcare looking to revolutionise modern medicine. An opportunity to make connections, discuss how to overcome market challenges and advance business goals.

Jumpcode Genomics Unveils an Expanded CRISPRclean® RNA Depletion Portfolio to Boost Discovery

Innovative new technologies empower medical and biopharma scientists and researchers to extract greater insights from the transcriptome.

Oncology Clinician-Scientist Jason Luke, MD Named physIQ Medical Advisor

– physIQ announced today that Jason Luke, MD, FACP, a recognized expert in immuno-oncology, professor of medicine, and clinical practitioner has been appointed to the company’s Medical Advisory Board. In this role, Dr. Luke will provide expert medical counsel for physIQ’s ongoing development of solutions to aide in oncology treatments, including physIQ’s development of digital biomarkers for inflammation.

RBQM market leader, CluePoints, marks its tenth anniversary as ICH E6 (R3) looks set to mandate the company’s data-driven approach across all clinical trials

RBQM market leader, CluePoints, marks its tenth anniversary as ICH E6 (R3) looks set to mandate the company’s data-driven approach across all clinical trials Risk-Based Quality Management: A front row seat to a decade of transformation

Exagen Announces Appointment of John Aballi as CEO

Exagen Inc. (Nasdaq: XGN), announced today that the company has appointed John Aballi as CEO and President. Longtime CEO and President Ron Rocca, who took the company public and built a robust growth business, is stepping down after 11 years at the helm.

InsightRX Offers Precision Dosing Support for New Drug Categories

InsightRX Offers Precision Dosing Support for New Drug Categories. New modules provide inpatient and outpatient dosing guidance for azole antifungals, solid organ transplant drugs, and inflammatory bowel disease biologics

Maternova Appoints Luna Mehrain, MD, MSc, as Chief Medical Officer Primary tabs

Maternova, Inc. announces the appointment of Luna M. Mehrain, MD, MSc, as Chief Medical Officer.

Samsung Biologics unlocks additional capacity for production at its newest Plant 4

Oxilio and Quotient Sciences Announce Regulatory Approval for Oxilio’s OXL001 Development Program

Oxilio, a pioneering drug development company repurposing existing drugs to address unmet needs in cancer treatment, and Quotient Sciences, a drug development and manufacturing accelerator, today announced an update on the development of Oxilio’s OXL001 product.

Sharp Adds New Talent with Clinical Leadership Appointments

Sharp, a leading provider of pharmaceutical packaging and clinical services, has strengthened its clinical leadership team with the appointment of Robert Feltz as Director, Analytical and Formulation Services and Michael MacNeir as Vice President, Global Business Development.

High-Standard Fermented Raw Materials that Satisfy the Quality Attributes of Healthcare Products

BOC Sciences is able to provide clients with high-standard fermented raw materials that satisfy the quality attributes of finished healthcare products.

New Cotiviti Solution Enables Health Plans to Predict and Improve Medicare Advantage Star Ratings

Amid industry-wide ratings decline, Star Intelligence helps organizations track, predict, and model CMS Star Ratings

ChargePoint Technology collaborates with STERIS to deliver sterile solution success for Evonik

Watson-Marlow introduces KROHNE flowmeter to safeguard accuracy of fluid flow

Watson-Marlow Fluid Technology Solutions announces the company now offers the KROHNE FLEXMAG 4050 C ® electromagnetic flowmeter for biopharmaceutical customers. As a highly accurate and reliable flow measuring system that seamlessly integrates with other WMFTS products, it reinforces the company’s position as a provider of total-solution packages for customers utilising fluid path processes.

CTL Amedica gets FDA clearance for MONDRIAN™ ALIF Cage System with Supplementary Fixation Plate

CTL Amedica Corporation has received official 510k clearance from the U.S. FDA to market its MONDRIAN Anterior Lumbar Interbody Fusion (ALIF) Cage System with Supplementary Fixation Plate. It features CTL Amedica’s proprietary TiCro surface technology, which significantly increases endplate contact surface area and enhances interlocking properties.

BOC Sciences Rolled Out PEG GMP Manufacture Services for Broad Applications

BOC Sciences recently launched the PEG GMP manufacture service, a novel solution that aims at providing GMP-grade PEG products for a wide scope of applications.